Integra LifeSciences Holdings Corp. (IART)
13.44
+0.03
(+0.22%)
USD |
NASDAQ |
Oct 09, 16:00
13.44
0.00 (0.00%)
After-Hours: 20:00
Integra LifeSciences Holdings Cash from Operations (Quarterly) : 22.80M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.80M |
| March 31, 2026 | 9.803M |
| December 31, 2025 | 11.82M |
| September 30, 2025 | 40.91M |
| June 30, 2025 | 8.919M |
| March 31, 2025 | -11.26M |
| December 31, 2024 | 50.74M |
| September 30, 2024 | 22.48M |
| June 30, 2024 | 40.40M |
| March 31, 2024 | 15.76M |
| December 31, 2023 | 58.75M |
| September 30, 2023 | 26.77M |
| June 30, 2023 | 28.28M |
| March 31, 2023 | 26.16M |
| December 31, 2022 | 85.33M |
| September 30, 2022 | 68.31M |
| June 30, 2022 | 66.48M |
| March 31, 2022 | 44.34M |
| December 31, 2021 | 69.28M |
| September 30, 2021 | 82.78M |
| June 30, 2021 | 91.29M |
| March 31, 2021 | 69.08M |
| December 31, 2020 | 80.26M |
| September 30, 2020 | 69.64M |
| June 30, 2020 | 33.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.81M |
| December 31, 2019 | 89.18M |
| September 30, 2019 | 64.24M |
| June 30, 2019 | 48.52M |
| March 31, 2019 | 29.48M |
| December 31, 2018 | 37.65M |
| September 30, 2018 | 79.25M |
| June 30, 2018 | 36.21M |
| March 31, 2018 | 41.53M |
| December 31, 2017 | 11.55M |
| September 30, 2017 | 45.24M |
| June 30, 2017 | 28.87M |
| March 31, 2017 | 28.88M |
| December 31, 2016 | 6.529M |
| September 30, 2016 | 46.77M |
| June 30, 2016 | 63.11M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 35.76M |
| September 30, 2015 | 19.35M |
| June 30, 2015 | 18.12M |
| March 31, 2015 | 31.62M |
| December 31, 2014 | 20.76M |
| September 30, 2014 | 31.08M |
| June 30, 2014 | 16.38M |
| March 31, 2014 | 11.25M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Penumbra, Inc. | 46.08M |
| Boston Scientific Corp. | 1.474B |
| Globus Medical, Inc. | 209.74M |
| Sight Sciences, Inc. | -5.663M |
| Abbott Laboratories | 2.488B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -43.28M |
| Cash from Financing (Quarterly) | -0.818M |
| Free Cash Flow | 11.60M |
| Free Cash Flow Per Share (Quarterly) | 0.1343 |
| Free Cash Flow to Equity (Quarterly) | 1.069M |
| Free Cash Flow to Firm (Quarterly) | 36.32M |
| Free Cash Flow Yield | 1.11% |